Experimental gel could become the first approved treatment for cancer wounds Phase 2 trial shows that a topical drug rapidly reduces malodor, pain, and improves quality of life for patients with malignant fungating wounds.

https://www.drugdiscoverynews.com/experimental-gel-could-become-the-first-approved-treatment-for-cancer-wounds-16906